YTHDC2 and metastatic malignant neoplasm in the lymph nodes: Notably, reduced expression of YTHDC2 has been observed in lung cancer and cigarette smoke-exposed cells, correlating with smoking history, advanced stage, invasion depth, lymph node metastasis, and poor outcomes.